It is important to exclude rhabdoid tumors in patients diagnosed with HB with AFP less than 100 ng/mL (or normal for gestational age) and in patients with tumors histologically diagnosed as HB with SCU component, since the treatment for these patients should be very different. This evidence concerns the gene AFP and rhabdoid tumor.